Life360 director gets RSUs, sells stock at $44
Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock.
Rhea-AI Filing Summary
Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock. He received a grant of 4,840 Restricted Stock Units at no cost, bringing his directly held RSUs to 5,676, which vest quarterly from May 15, 2026, subject to continued service. Through the John Coghlan Living Trust, he sold a total of 4,000 shares in open-market transactions at weighted average prices of about $43.95 and $44.64, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. After these sales, that trust holds 28,431 shares, while a separate Grantor Retained Annuity Trust holds 55,494 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock | 3,796 | $43.95 | $167K |
| Sale | Common stock | 204 | $44.64 | $9K |
| Grant/Award | Common stock | 4,840 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date.
- F2. Includes 5,676 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- F3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- F4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.53 to $44.52, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F5. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.64, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
Key Figures
Key Terms
Restricted Stock Units ("RSUs") financial
Rule 10b5-1 trading plan regulatory
Grantor Retained Annuity Trust financial
weighted average price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.